Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Abbvie Stemcentrx Llc patents


Recent patent applications related to Abbvie Stemcentrx Llc. Abbvie Stemcentrx Llc is listed as an Agent/Assignee. Note: Abbvie Stemcentrx Llc may have other listings under different names/spellings. We're not affiliated with Abbvie Stemcentrx Llc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Abbvie Stemcentrx Llc-related inventors


Novel modulators and methods of use

Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat hyperproliferative disorders are provided.. . ... Abbvie Stemcentrx Llc

Calicheamicin constructs and methods of use

Provided herein are antibody drug conjugates (adcs) comprising calicheamicin and methods of using the same to treat proliferative disorders.. . ... Abbvie Stemcentrx Llc

Anti-ptk7 antibody-drug conjugates

The present invention provides anti-ptk7 antibody-drug conjugates and methods for preparing and using the same.. . ... Abbvie Stemcentrx Llc

Identification and enrichment of cell subpopulations

Markers useful for the identification, characterization and, optionally, the enrichment or isolation of tumorigenic cells or cell subpopulations are disclosed.. . ... Abbvie Stemcentrx Llc

Anti-dll3 chimeric antigen receptors and methods of use

Provided herein are novel anti-dll3 chimeric antigen receptors and methods of using the same to treat proliferative disorders.. . ... Abbvie Stemcentrx Llc

Methods of delivering dll3 antibody drug conjugates

Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.. . ... Abbvie Stemcentrx Llc

Methods of making dll3 antibody drug conjugates

Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.. . ... Abbvie Stemcentrx Llc

Anti-dll3 antibody drug conjugates and methods of use

Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.. . ... Abbvie Stemcentrx Llc

Anti sez6 antibodies and methods of use

Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.. . ... Abbvie Stemcentrx Llc

Anti-dll3 antibody drug conjugates

Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.. . ... Abbvie Stemcentrx Llc

Anti-cldn chimeric antigen receptors and methods of use

Provided herein are novel anti-cldn chimeric antigen receptors and methods of using the same to treat proliferative disorders.. . ... Abbvie Stemcentrx Llc

Novel anti-mfi2 antibodies and methods of use

Provided are novel anti-mfi2 antibodies and antibody drug conjugates, and methods of using such anti-mfi2 anti-bodies and antibody drug conjugates to treat cancer.. . ... Abbvie Stemcentrx Llc

Kits containing dll3 antibody drug conjugates

Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.. . ... Abbvie Stemcentrx Llc

Dll3 modulators and methods of use

Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.. . ... Abbvie Stemcentrx Llc

09/21/17 / #20170266315

Anti-dll3 antibody drug conjugates for treating cancer

Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.. . ... Abbvie Stemcentrx Llc

09/21/17 / #20170266314

Methods of making dll3 antibody drug conjugates

Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.. . ... Abbvie Stemcentrx Llc

09/21/17 / #20170266313

Methods of delivering dll3 antibody drug conjugates

Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.. . ... Abbvie Stemcentrx Llc

09/21/17 / #20170266312

Anti-dll3 antibody drug conjugates

Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.. . ... Abbvie Stemcentrx Llc

05/18/17 / #20170137533

Anti-dll3 antibodies and drug conjugates for use in melanoma

Anti-dll3 antibodies and antibody drug conjugates for use in the diagnosis and treatment of melanoma.. . ... Abbvie Stemcentrx Llc

05/04/17 / #20170121416

Anti-cd324 monoclonal antibodies and uses thereof

Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.. . ... Abbvie Stemcentrx Llc

03/23/17 / #20170081419

Novel modulators and methods of use

Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat hyperproliferative disorders are provided.. . ... Abbvie Stemcentrx Llc

03/16/17 / #20170073430

Novel anti-rnf43 antibodies and methods of use

The invention discloses novel anti-rnf43 antibodies and derivatives thereof, including antibody drug conjugates, and methods of using such anti-rnf43 antibodies and antibody drug conjugates to diagnose and treat cancer.. . ... Abbvie Stemcentrx Llc

02/16/17 / #20170044271

Novel anti-dpep3 antibodies and methods of use

Provided herein are novel anti-dpep3 antibodies and antibody drug conjugates (adc), including derivatives thereof, and methods of using the same to treat proliferative disorders.. . ... Abbvie Stemcentrx Llc

02/02/17 / #20170029530

Novel anti-dpep3 antibodies and methods of use

Provided herein are novel anti-dpep3 antibodies and antibody drug conjugates (adc), including derivatives thereof, and methods of using the same to treat proliferative disorders.. . ... Abbvie Stemcentrx Llc

01/05/17 / #20170000901

Dll3 modulators and methods of use

Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.. . ... Abbvie Stemcentrx Llc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Abbvie Stemcentrx Llc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Abbvie Stemcentrx Llc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###